October 10, 2016 – Cancer News Review
In this month's podcast, Johns Hopkins Kimmel Cancer Director William Nelson discusses drugs approved by the FDA including those that help cancer with the BRCA gene, the cost of breast cancer treatment and the financial burdens of cancer care and treatment.
0:26 PARP inhibitors
1:27 Cancers that don’t have BRCA defects another drug helps
2:26 Are ones approved by FDA
2:40 Physical properties of cells and metastasis
3:41 inhibition might help
3:50 Costs of breast cancer treatment
4:51 More for trastuzumab
5:51 Ready to engage in life and what is the financial burden?
6:51 Value in care needed
7:15 Data on childhood cancer survival